Pennsylvania vaccine maker Inovio Pharmaceuticals and South Korea's GeneOne Life Sciences said Monday that they had received approval from U.S. regulators to start testing a DNA vaccine, known as GLS-5700, on humans.
The early stage study will include 40 healthy subjects. It is primarily designed to assess the safety of the vaccine but will also measure the immune response generated by the injection. Zika is believed to be responsible for causing thousands of babies to be born with shrunken heads in Brazil and elsewhere.
Information Source http://www.ndtv.com
